Consumer Survey - Disclosure of Industry Payments to Physicians
Americans want to know about physician ties to pharmaceutical companies
According to a Prescription Project survey, a majority of Americans (64%) say that it is important to know their physician’s financial ties to pharmaceutical companies and 68% would support legislation requiring pharmaceutical companies to disclose gifts to doctors. The survey showed that most Americans disapprove of even small gifts to physicians and believe that the pharmaceutical industry has a large influence over prescribing decisions.
The pharmaceutical industry spends more than $20 billion annually marketing to physicians, much of that marketing in the form of free gifts – ranging from pens and meals to pharmaceutical samples and continuing medical education classes.
The survey was conducted by the national firm ICR during June 4, 2008 – June 8, 2008; 1009 adults from across the United States responded.
Download the full PDF for more information.
The Pew Charitable Trusts appreciates this opportunity to submit comments to CMS's "Information Collection Activities" draft guidance. We suggest that both the research and non-research payment templates be modified in order to make it easier for consumers to identify which drugs, devices, biologicals, or medical supplies are associated with particular transfers of value. More info
On Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights. More info
"The Obama administration issued a new rule this month that requires the makers of prescription drugs and other medical products to disclose what they pay doctors for various purposes, like consulting or speaking on behalf of the manufacturer. This overdue rule adds much-needed weight to previous, more limited disclosure requirements." More info
Allan Coukell, director of medical programs for The Pew Charitable Trusts, issued the following statement in response to the Centers for Medicare & Medicaid Services' final rule for implementing the Physician Payments Sunshine Act, which will bring transparency to the financial relationships between physicians and drug and medical device companies. More info
In 2011, the pharmaceutical industry spent nearly $29 billion on drug promotion — more than $25 billion on marketing directly to physicians and almost $4 billion on advertising directly to consumers (mainly through television commercials). This multi-pronged approach is designed to promote its products by influencing doctors’ prescribing practices.